Norethisterone & Period Delay: UK/Spain

Can norethisterone delay a period?

Some UK products are licensed for period delay, but Spanish Primolut-Nor does not list this indication. Suitability depends on the exact product and clinical assessment. Period-delay treatment is not contraception.

What is norethisterone?

Norethisterone is a synthetic progestogen, with effects similar to progesterone. Product names, ingredients and authorised uses differ by country. The UK products Utovlan and Primolut N contain norethisterone base. Spanish Primolut-Nor contains norethisterone acetate; its listed indications are secondary amenorrhoea and endometriosis, not period postponement. These products must not be treated as interchangeable period-delay options.

This article explains the UK period-delay information and its limits for readers in Spain. It does not establish EU-wide authorisation, current availability or a Spanish treatment protocol. The norethisterone information page is not confirmation that a particular product or indication is available to you.

How it affects menstruation

The fall in progesterone during the menstrual cycle helps trigger shedding of the womb lining. A progestogen can postpone this withdrawal bleed; bleeding usually returns after treatment ends, but timing varies. Period-delay norethisterone is not a contraceptive. It must not be relied on to prevent pregnancy.

What the named UK product information says

These are descriptions of product information, not instructions to start treatment:

UK product	Period-postponement information	Important distinction
Utovlan 5 mg	One tablet three times daily, starting three days before the expected period; menstruation usually follows within three days of finishing	This section does not specify the 10–14-day maximum quoted for Primolut N; that does not authorise unlimited use
Primolut N 5 mg	One tablet three times daily, starting three days before the expected period, for no longer than 10–14 days; bleeding should follow 2–3 days after stopping	Restricted to people not at risk of pregnancy during the treatment cycle

Neither UK regimen establishes a period-delay indication or dose for Spanish norethisterone acetate. A doctor must assess the actual product, medical history, cycle, pregnancy possibility and clot risk, and decide whether any treatment is appropriate. Follow the prescribed instructions and that product's leaflet; do not extend a course or transfer instructions between brands. See the Utovlan and Primolut N product information, sections 2 and 4.1–4.2.

Who needs assessment?

A clinician needs to know whether your cycle is regular, whether pregnancy is possible, your medical conditions and every medicine or supplement you take. A predictable period date alone does not establish suitability. Pregnancy must be excluded when indicated; if bleeding does not follow a course, seek advice before another course.

If you already use hormonal contraception, discuss the specific method. Some combined-pill regimens can postpone a withdrawal bleed; a progestogen-only pill cannot reliably prevent a period. Ring, patch, implant and injection use cannot be grouped into one reliable immediate-delay strategy. Do not change your contraceptive routine yourself. NHS SPS guidance describes method-specific options in the UK, not a Spanish prescription.

Possible side effects and bleeding changes

Reported effects include nausea, headache, breast tenderness, fluid retention or bloating, mood or libido changes, irregular bleeding and skin reactions. Frequencies depend on the product and use; this is not a list of effects that are all common. Consult the actual leaflet and seek advice if effects are troublesome or your mood worsens.

Bleeding can change during or after treatment, and the time taken to return to your usual cycle varies. A short course still requires assessment of your individual risks. Persistent or unexplained bleeding needs assessment.

Blood clots and urgent symptoms

Clot risk requires individual assessment. Tell the doctor about your own or your family's clot history, smoking, age, weight, planned surgery, prolonged immobility and long journeys. A short course does not remove contraindications. The labels contain additional vascular warnings; do not assume that all progestogen products have the same risk profile.

Stop treatment and seek urgent medical help for a painful swollen leg, sudden chest pain, breathlessness or sudden neurological symptoms suggesting a clot. Call 112 for an emergency.

Utovlan (UK): stop treatment and seek urgent medical assessment if a new migraine-type headache or jaundice develops. Its product information also requires an eye assessment for sudden visual impairment, double vision or protrusion of an eye: stop taking it and obtain urgent assessment before continuing, so serious eye conditions can be excluded. Primolut N (UK) and Primolut-Nor (Spain): stop immediately and seek urgent medical assessment for a new migraine-type headache, sudden visual or other sensory changes, or jaundice. These actions do not make the products or their authorised uses interchangeable. See each product's section 4.4. Discuss surgery and immobilisation with the prescriber in advance; do not choose your own stop/restart schedule.

Contraindications are product-specific

UK Utovlan contraindications include pregnancy, hypersensitivity, previous idiopathic or current venous thromboembolism, active or recent arterial thromboembolic disease, disturbed liver function, specified pregnancy-related jaundice/pruritus or pemphigoid, undiagnosed irregular vaginal bleeding and porphyria. Its high-dose breast-cancer indication is a separate specialist use, not evidence that period-delay treatment is suitable for someone with cancer. See sections 4.1 and 4.3–4.4 of its product information.

UK Primolut N and Spanish Primolut-Nor have different exclusions, including pregnancy, breastfeeding, a history of migraine with focal neurological symptoms, diabetes with vascular involvement, and relevant thrombotic, severe liver and hormone-dependent malignant conditions. Migraine with focal symptoms is not restricted to “severe” cases and has no general “specialist exception”. Their full lists and histories/risk criteria must be checked for the exact product. The Spanish Primolut-Nor information, section 4.3, also contraindicates concomitant ombitasvir/paritaprevir/ritonavir and dasabuvir. Do not use another product's shorter list to assume eligibility.

Heart or kidney disease, epilepsy, diabetes without vascular involvement, migraine and depression can also affect assessment or monitoring, depending on the product. A precaution must not replace a contraindication that applies to you.

Interactions, contraception and alternatives

Tell the clinician about antiepileptics, rifampicin, St John's wort and all other medicines or supplements. Do not stop an existing medicine to make yourself eligible. If sexually active and pregnancy is possible, discuss effective contraception; period-delay treatment does not provide it.

Alternatives depend on your current contraceptive and medical history. Do not assume a progestogen-only pill adjustment will reliably delay bleeding. If delay is not essential, menstrual cups or period underwear may help manage bleeding during an event without changing hormonal treatment.

Prescrivia's role and access in Spain

Prescrivia is a technology intermediary connecting patients with independent EU-registered doctors and licensed pharmacies. Doctors decide independently whether assessment, investigation or treatment is appropriate; pharmacies remain responsible for dispensing. No prescription, product or outcome is guaranteed.

Spain prohibits distance sale of prescription medicines. A UK indication, an online assessment or cross-border prescription recognition does not establish a permitted Spanish supply route. The actual country-specific prescribing and dispensing arrangement needs verification. See AEMPS information on websites and apps.

Sources and review limits

The linked UK SmPCs, Spanish Primolut-Nor SmPC and NHS SPS guidance support the product and jurisdiction distinctions above. They do not prove stock, individual suitability or approval of this article. See the current clinical, legal and language review statuses for this edition. This article is general information, not medical advice; read the actual leaflet and consult a qualified clinician before hormonal treatment.

Norethisterone and period delay: UK product information and Spain limits